Preparation process of colostrum basic protein

Through degreasing casein removal, enzymatic decomposition, isoelectric point precipitation, ultrafiltration and purification processes, combined with magnetic immobilized pepsin and cation exchange resin, high-purity colostrum alkaline protein was successfully prepared, solving the extraction problems in the prior art , improves its application effect in preventing osteoporosis.

CN118994359AInactive Publication Date: 2024-11-22JIACHENG ZHIHE (BEIJING) TECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411392023.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-08
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The prior art is difficult to effectively extract and prepare colostrum alkaline protein, which affects its application in the prevention of osteoporosis.

Method used

The process of degreasing casein removal, enzymatic lysis, isoelectric point precipitation, primary ultrafiltration, secondary ultrafiltration, purification and sterilization and lyophilization were used to separate and concentrate proteins with magnetic immobilized pepsin and cation exchange resin, combined with high pressure Pulse electric field sterilization to prepare high-purity colostrum alkaline protein.

Benefits of technology

It realizes efficient extraction and concentration of colostrum alkaline protein, reduces sensitization, and improves its application value in the prevention of osteoporosis.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention discloses a preparation process of colostrum basic protein, and relates to the technical field of protein separation. The preparation method comprises the following steps: during preparation of colostrum basic protein, firstly, modifying magnetic ferroferric oxide nanoparticles by using tetraethyl orthosilicate and 3-(2, 3-epoxypropoxy) propyltriethoxysilane in sequence to prepare modified silicon shell magnetic nanoparticles; pepsase is immobilized on the modified silicon shell magnetic nanoparticles to prepare magnetic immobilized pepsase; the colostrum basic protein is separated and purified from the bovine colostrum through the steps of degreasing, casein removal, enzymolysis, isoelectric precipitation, primary ultrafiltration, secondary ultrafiltration, purification, sterilization and freeze-drying. The colostrum basic protein prepared by the method has the advantages of high active protein content and low sensitization.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of protein separation, in particular to a preparation process of colostrum alkaline protein. Background Art

[0002] In recent years, with the improvement of my country's comprehensive strength, people's living conditions and economic level, more and more people choose targeted nutritional products to regulate their bodies. Among them, the issue of bone development and health has been widely concerned, especially the bone health of children, adolescents and middle-aged and elderly people. However, many people now only know that calcium supplementation is good for bone health, but they know nothing about how to supplement calcium correctly and effectively.

[0003] Cow's milk mainly contains two types of proteins: casein and whey protein. Casein accounts for about 80% of cow's milk protein and is the main component of cow's milk, while whey protein accounts for about 20%. Milk not only contains nutrients that promote growth and development, but also contains biological functional compounds such as lactose and casein phosphopeptide that affect bone metabolism. These substances have a certain effect on the prevention and treatment of osteoporosis.

[0004] Bovine colostrum is the milk of dairy cows after giving birth. As a nutritional treasure for more than 50 years, it not only has a high protein content, but also contains a variety of components that affect immunity, growth and development, and bone health, including immunoglobulins, lactoferrin, colostrum alkaline protein, lactoperoxidase, lysozyme, growth factors, oligosaccharides, etc. Among them, colostrum alkaline protein is a colostrum essence with great application value that has been successfully extracted internationally recently. Compared with mature milk, the colostrum alkaline protein content in bovine colostrum is higher.

[0005] Colostrum basic protein is a type of active protein, with a content of only 0.04% in bovine colostrum. Ordinary cow's milk also contains a small amount of colostrum basic protein, with a content of about 0.015%. Studies have shown that colostrum basic protein is an active protein with a molecular weight of about 1 to 30KDa, which can directly act on bone cells, promote bone cell proliferation, greatly enhance calcium absorption, and combine with calcium to effectively increase human bone density and bone development in children and adolescents. Once absorbed, it can promote bone growth, and heat treatment and digestive enzyme action will not destroy its function. Therefore, colostrum basic protein can effectively prevent osteoporosis. Summary of the invention

[0006] The purpose of the present invention is to provide a preparation process of colostrum basic protein to solve the problems existing in the prior art.

[0007] In order to solve the above technical problems, the present invention provides the following technical solutions:

[0008] A preparation process of colostrum alkaline protein, mainly comprising the following preparation steps: defatting and removing casein, enzymatic hydrolysis, isoelectric precipitation, primary ultrafiltration, secondary ultrafiltration, purification, sterilization and freeze-drying;

[0009] The enzymatic hydrolysis is performed using magnetically immobilized pepsin;

[0010] The primary ultrafiltration is performed using an ultrafiltration membrane cross-flow with a molecular weight cut-off of 30 KDa;

[0011] The secondary ultrafiltration is carried out by cross-flow using an ultrafiltration membrane with a molecular weight cut-off of 1 KDa;

[0012] The purification uses cation exchange resin for adsorption and elution;

[0013] The magnetically immobilized pepsin is prepared by immobilizing pepsin on modified silica shell magnetic nanoparticles;

[0014] The modified silicon shell magnetic nanoparticles are prepared by sequentially modifying magnetic ferrosoferric oxide nanoparticles with tetraethyl orthosilicate and 3-(2,3-epoxypropoxy)propyltriethoxysilane.

[0015] As an optimization, the preparation process of the colostrum basic protein mainly includes the following steps:

[0016] (1) Degreasing and removing casein: fresh bovine colostrum is centrifuged at 4000-5000 rpm and 4°C for 15-20 min, the upper layer of fat is discarded, the clear liquid is adjusted to pH 4.6 with 1 mol / L hydrochloric acid aqueous solution, allowed to stand for 30-40 min, centrifuged at 4000-5000 rpm and 4°C for 15-20 min, and the whey liquid is filtered;

[0017] (2) Enzymatic hydrolysis: the pH of the whey liquid was adjusted to 2.0 with a 2 mol / L hydrochloric acid aqueous solution, and the whey liquid was placed in a water bath at 37° C. for 10 to 12 min, and magnetic immobilized pepsin was added in a mass ratio of magnetic immobilized pepsin to whey liquid of 1:(20 to 25), and the whey liquid was placed in a constant temperature water bath at 37° C. at 150 to 200 r / min for 1.5 to 2 h, and the magnetic immobilized pepsin was separated by applying an external magnetic field to obtain a whey hydrolyzate;

[0018] (3) Isoelectric precipitation: The whey enzymatic hydrolysate was adjusted to pH 4.8 with 1 mol / L sodium hydroxide solution, incubated in a 60°C water bath for 70-80 min, centrifuged at 4000-5000 rpm for 25-30 min, and the supernatant was collected to obtain a whey fraction;

[0019] (4) primary ultrafiltration: the whey separation liquid is subjected to cross-flow ultrafiltration using an ultrafiltration membrane with a molecular weight cut-off of 30 KDa, under the following conditions: a cross-flow flow rate of 6 to 7 L / min, a pressure of 0.45 to 0.55 MPa, and water is replenished during the process to obtain a whey ultrafiltration filtrate;

[0020] (5) secondary ultrafiltration: the whey ultrafiltration filtrate is subjected to cross-flow ultrafiltration using an ultrafiltration membrane with a molecular weight cut-off of 1 KDa, under the following conditions: a cross-flow flow rate of 6 to 7 L / min, a pressure of 0.75 to 0.85 MPa, and the volume of the whey ultrafiltration filtrate is concentrated to 4.4% to 5.3% of the original volume to obtain a whey ultrafiltration retentate;

[0021] (6) Purification: The whey ultrafiltration retentate is pumped into a cation exchange resin column at a rate of 1.5 to 2 ml / min, and eluted at 40° C. using 0.05 mol / L phosphate buffer with a pH of 7.0 at a rate of 2.4 to 2.6 ml / min until no protein is detected to obtain an eluate, and the eluate is subjected to cross-flow ultrafiltration using an ultrafiltration membrane with a molecular weight cutoff of 1 kDa under the following conditions: a cross-flow flow rate of 6 to 7 L / min and a pressure of 0.75 to 0.85 MPa, and concentrated to 2% to 3% of the original volume, and the retentate is taken to obtain a whey concentrate;

[0022] (7) Sterilization and freeze-drying: The whey concentrate is placed in a high-voltage pulse electric field, treated at 5-10°C for 15-20 seconds, and vacuum freeze-dried for 16-20 hours to obtain colostrum alkaline protein.

[0023] As an optimization, the preparation method of magnetically immobilized pepsin in step (2) comprises the following preparation steps:

[0024] (A) By weight, 0.5-0.6 parts of magnetic ferroferric oxide nanoparticles, 3-4 parts of 2.7 mol / L ammonia water, 40-60 parts of ethanol, and 10-15 parts of pure water were mixed evenly, ultrasonically dispersed for 50-60 minutes, 0.8-1.2 parts of tetraethyl orthosilicate were added dropwise at a rate of 1-2 drops per second, stirred at 200-300 r / min for 5-6 hours at room temperature, allowed to stand for 2-3 hours, separated by applying a magnetic field, washed with pure water until neutral, then washed with anhydrous ethanol and ether for 3-4 times each, and vacuum dried at 60-80° C. for 10-12 hours to obtain silicon shell magnetic nanoparticles;

[0025] (B) mixing silica shell magnetic nanoparticles, 3-(2,3-epoxypropoxy)propyltriethoxysilane and ethanol in a mass ratio of 1:0.4:10, ultrasonicating at room temperature for 30 to 40 minutes, allowing to stand for 1 to 1.5 hours, separating by applying a magnetic field, vacuum drying at 30 to 40°C for 20 to 30 minutes, sealing in a 40°C water atmosphere for 30 to 40 minutes, allowing to stand in an oven at 60 to 70°C for 12 to 14 hours, washing with ethanol 3 to 4 times, and vacuum drying at 40 to 50°C for 3 to 4 hours to obtain modified silica shell magnetic nanoparticles;

[0026] (C) 1 mg / ml pepsin buffer solution and modified silica shell magnetic nanoparticles were mixed uniformly in a mass ratio of 1:(0.1-0.2), and stirred at 150-200 r / min for 8-10 h in a constant temperature water bath at pH 4 at 15-25°C. The mixture was separated by an external magnetic field, washed with deionized water for 5-6 times, and vacuum dried at 15-20°C for 8-10 h to obtain magnetic immobilized pepsin.

[0027] As an optimization, the water replenishment in step (4) is to replenish an equal volume of pure water once for every filtrate of one third of the volume of the whey separator collected, and replenish 12 to 15 times in total.

[0028] As an optimization, the cation exchange resin in step (6) is one of D72, D61, D81, D113, D001, and 001×7.

[0029] As an optimization, the field strength of the high-voltage pulse electric field in step (7) is 30 to 50 kV / cm, and the pulse frequency is 200 to 400 Hz.

[0030] As an optimization, the particle size of the magnetic ferroferric oxide nanoparticles in step (A) is 15 to 20 nm.

[0031] Compared with the prior art, the beneficial effects achieved by the present invention are:

[0032] When preparing colostrum alkaline protein, the present invention first uses tetraethyl orthosilicate and 3-(2,3-epoxypropoxy)propyltriethoxysilane to modify magnetic ferrosoferric oxide nanoparticles in sequence to obtain modified silica shell magnetic nanoparticles; pepsin is fixed on the modified silica shell magnetic nanoparticles to obtain magnetic immobilized pepsin; and colostrum alkaline protein is separated and purified from bovine colostrum through the steps of defatting and removing casein, enzymolysis, isoelectric precipitation, primary ultrafiltration, secondary ultrafiltration, purification, sterilization and freeze drying.

[0033] Firstly, the magnetic ferroferric oxide nanoparticles were modified by tetraethyl orthosilicate so that their surface was coated with a layer of silicon dioxide to protect the internal magnetic ferroferric oxide nanoparticles from acid, alkali and air corrosion. Then, 3-(2,3-epoxypropoxy)propyltriethoxysilane was used to further modify the nanoparticles to introduce epoxy groups onto the surface of the nanoparticles. Subsequently, pepsin reacted with the epoxy groups through a covalent bond reaction to fix the pepsin thereon, thereby obtaining magnetic immobilized pepsin.

[0034] Secondly, after the bovine colostrum is defatted by centrifugation and casein is removed by isoelectric precipitation, a whey solution mainly containing whey protein is obtained, and then the whey solution is enzymatically hydrolyzed by magnetically immobilized pepsin. Preliminary experiments show that under this condition, pepsin mainly hydrolyzes α-lactalbumin in whey protein, and then β-lactoglobulin is removed by isoelectric precipitation. α-lactalbumin and β-lactoglobulin in bovine colostrum are the main sources of allergies. This method removes these two proteins to reduce the allergenicity of colostrum alkaline protein; then, a molecular weight cutoff of 30KDa is used. The ultrafiltration membrane is used for one ultrafiltration, and then the ultrafiltration membrane with a molecular weight cutoff of 1KDa is used for a second ultrafiltration. Both ultrafiltrations are performed using the cross-flow method to reduce membrane pollution. The filtrate is collected in the first ultrafiltration to remove large molecular proteins greater than 30KDa in the whey protein. Subsequently, the retentate is collected in the secondary ultrafiltration to remove small molecular amino acids, inorganic salts, short peptide chains, etc. less than 1KDa, and the whey liquid is concentrated at the same time. The filtrate of the secondary ultrafiltration contains a large number of short peptide chains and amino acids after the enzymatic hydrolysis of α-lactalbumin, which can also be further recovered and extracted for utilization.

[0035] Finally, a cation exchange resin is used to adsorb the colostrum alkaline protein in the whey ultrafiltration retentate, and a buffer solution is used for elution after complete adsorption. The colostrum alkaline protein is separated by the specific adsorption of the cation exchange resin on the alkaline protein, and since other components in the bovine colostrum have been separated, the colostrum alkaline protein is equivalent to being concentrated and enriched, which in disguise improves the separation efficiency of the cation exchange resin; the eluate is ultrafiltered once again using an ultrafiltration membrane with a molecular weight cutoff of 1KDa to remove small molecule inorganic salts therein, and concentrated to obtain a whey concentrate; the use of a high-voltage pulsed electric field can effectively kill bacteria and reduce the probability of protein denaturation. DETAILED DESCRIPTION

[0036] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.

[0037] The cation exchange resin used in the following examples and comparative examples is D001.

[0038] The magnetic immobilized pepsin used in the following examples and comparative examples was prepared according to the following preparation method:

[0039] (A) By weight, 0.5 parts of magnetic ferroferric oxide nanoparticles, 3 parts of 2.7 mol / L ammonia water, 50 parts of ethanol, and 12 parts of pure water were mixed evenly, ultrasonically dispersed for 60 min, 0.8 parts of tetraethyl orthosilicate was added dropwise at a rate of 1 drop per second, stirred at 250 r / min for 6 h at room temperature, allowed to stand for 3 h, separated by an external magnetic field, washed with pure water until neutral, then washed with anhydrous ethanol and ether 3 times each, and dried in vacuo at 70°C for 11 h to obtain silica shell magnetic nanoparticles;

[0040] (B) Silica shell magnetic nanoparticles, 3-(2,3-epoxypropoxy)propyltriethoxysilane and ethanol were mixed uniformly in a mass ratio of 1:0.4:10, ultrasonicated at room temperature for 35 minutes, allowed to stand for 1 hour, separated by an external magnetic field, vacuum dried at 35°C for 25 minutes, sealed in a 40°C water atmosphere for 35 minutes, allowed to stand in an oven at 70°C for 14 hours, washed with ethanol 4 times, and vacuum dried at 50°C for 3 hours to obtain modified silica shell magnetic nanoparticles;

[0041] (C) 1 mg / ml pepsin buffer solution and modified silica shell magnetic nanoparticles were mixed at a mass ratio of 1:0.15, and reacted at pH 4, constant temperature water bath of 15°C, and 150 r / min for 10 h. The mixture was separated by an external magnetic field, washed with deionized water for 5 times, and vacuum dried at 20°C for 8 h to obtain magnetic immobilized pepsin.

[0042] Embodiment 1:

[0043] A preparation process of colostrum alkaline protein, comprising the following preparation steps:

[0044] (1) Degreasing and removing casein: fresh bovine colostrum was centrifuged at 4000 rpm and 4°C for 20 min, the upper fat layer was discarded, the clear liquid was adjusted to pH 4.6 with 1 mol / L hydrochloric acid aqueous solution, allowed to stand for 30 min, centrifuged at 4000 rpm and 4°C for 20 min, and the whey liquid was filtered;

[0045] (2) Enzymatic hydrolysis: The pH of the whey liquid was adjusted to 2.0 with a 2 mol / L hydrochloric acid aqueous solution, and the whey liquid was incubated in a water bath at 37°C for 10 min. The magnetic immobilized pepsin was added in a mass ratio of 1:20 to the whey liquid, and the whey liquid was incubated in a water bath at 37°C at 150 r / min for 2 h. The magnetic immobilized pepsin was separated by an external magnetic field to obtain a whey hydrolysate;

[0046] (3) Isoelectric precipitation: The pH of the whey hydrolysate was adjusted to 4.8 with 1 mol / L sodium hydroxide solution, incubated in a 60°C water bath for 70 min, centrifuged at 4000 rpm for 30 min, and the supernatant was collected to obtain a whey fraction;

[0047] (4) primary ultrafiltration: the whey separator was subjected to cross-flow ultrafiltration using an ultrafiltration membrane with a molecular weight cutoff of 30 KDa, under the following conditions: a cross-flow flow rate of 6 L / min and a pressure of 0.55 MPa, during which an equal volume of pure water was added once for each filtrate of one third of the volume of the whey separator collected, and the addition was performed 12 times in total to obtain a whey ultrafiltration filtrate;

[0048] (5) Secondary ultrafiltration: The whey ultrafiltration filtrate is subjected to cross-flow ultrafiltration using an ultrafiltration membrane with a molecular weight cut-off of 1 KDa, under the following conditions: a cross-flow flow rate of 6 L / min, a pressure of 0.85 MPa, and the volume of the whey ultrafiltration filtrate is concentrated to 4.4% of the original volume to obtain a whey ultrafiltration retentate;

[0049] (6) Purification: The whey ultrafiltration retentate was pumped into a cation exchange resin column at a rate of 1.5 ml / min, and eluted at 40° C. using 0.05 mol / L phosphate buffer with a pH of 7.0 at a rate of 2.4 ml / min until no protein was detected to obtain an eluate, and the eluate was subjected to cross-flow ultrafiltration using an ultrafiltration membrane with a molecular weight cutoff of 1 kDa under the following conditions: a cross-flow flow rate of 6 L / min and a pressure of 0.75 MPa, and concentrated to 2% of the original volume, and the retentate was taken to obtain a whey concentrate;

[0050] (7) Sterilization and freeze-drying: The whey concentrate is placed in a high-voltage pulse electric field, treated at 5°C for 20 seconds, and vacuum freeze-dried for 16 hours to obtain colostrum alkaline protein.

[0051] Embodiment 2:

[0052] A preparation process of colostrum alkaline protein, comprising the following preparation steps:

[0053] (1) Degreasing and removing casein: fresh bovine colostrum was centrifuged at 4500 rpm and 4°C for 18 min, the upper fat layer was discarded, the clear liquid was adjusted to pH 4.6 with 1 mol / L hydrochloric acid aqueous solution, allowed to stand for 35 min, centrifuged at 4500 rpm and 4°C for 18 min, and the whey liquid was filtered;

[0054] (2) Enzymatic hydrolysis: The pH of the whey liquid was adjusted to 2.0 with a 2 mol / L hydrochloric acid aqueous solution, and the whey liquid was incubated in a water bath at 37°C for 11 min. The magnetic immobilized pepsin was added in a mass ratio of 1:22 to the whey liquid, and the whey liquid was incubated in a water bath at 37°C at 200 r / min for 1.5 h. The magnetic immobilized pepsin was separated by an external magnetic field to obtain a whey hydrolysate;

[0055] (3) Isoelectric precipitation: The pH of the whey hydrolysate was adjusted to 4.8 with 1 mol / L sodium hydroxide solution, incubated in a 60°C water bath for 75 min, centrifuged at 4500 rpm for 28 min, and the supernatant was collected to obtain a whey fraction;

[0056] (4) primary ultrafiltration: the whey separator was subjected to cross-flow ultrafiltration using an ultrafiltration membrane with a molecular weight cutoff of 30 KDa, under the following conditions: a cross-flow rate of 6.5 L / min and a pressure of 0.5 MPa, during which an equal volume of pure water was added once for each filtrate of one third of the volume of the whey separator collected, and the addition was performed 13 times in total to obtain a whey ultrafiltration filtrate;

[0057] (5) Secondary ultrafiltration: The whey ultrafiltration filtrate is subjected to cross-flow ultrafiltration using an ultrafiltration membrane with a molecular weight cutoff of 1 KDa, under the following conditions: a cross-flow flow rate of 6.5 L / min, a pressure of 0.8 MPa, and the volume of the whey ultrafiltration filtrate is concentrated to 4.9% of the original volume to obtain a whey ultrafiltration retentate;

[0058] (6) Purification: The whey ultrafiltration retentate was pumped into a cation exchange resin column at a rate of 1.8 ml / min, and eluted at 40° C. using 0.05 mol / L phosphate buffer with a pH of 7.0 at a rate of 2.5 ml / min until no protein was detected to obtain an eluate, and the eluate was subjected to cross-flow ultrafiltration using an ultrafiltration membrane with a molecular weight cutoff of 1 kDa under the following conditions: a cross-flow flow rate of 6.5 L / min and a pressure of 0.8 MPa, and concentrated to 2.5% of the original volume, and the retentate was taken to obtain a whey concentrate;

[0059] (7) Sterilization and freeze-drying: The whey concentrate is placed in a high-voltage pulse electric field, treated at 8°C for 18 seconds, and vacuum freeze-dried for 18 hours to obtain colostrum alkaline protein.

[0060] Embodiment 3:

[0061] A preparation process of colostrum alkaline protein, comprising the following preparation steps:

[0062] (1) Degreasing and removing casein: fresh bovine colostrum was centrifuged at 5000 rpm and 4°C for 15 min, the upper fat layer was discarded, the clear liquid was adjusted to pH 4.6 with 1 mol / L hydrochloric acid aqueous solution, allowed to stand for 40 min, centrifuged at 5000 rpm and 4°C for 15 min, and the whey liquid was filtered;

[0063] (2) Enzymatic hydrolysis: The pH of the whey liquid was adjusted to 2.0 with a 2 mol / L hydrochloric acid aqueous solution, and the whey liquid was incubated in a water bath at 37°C for 12 min. The magnetic immobilized pepsin was added in a mass ratio of 1:25 to the whey liquid, and the whey liquid was incubated in a water bath at 37°C at 200 r / min for 1.5 h. The magnetic immobilized pepsin was separated by an external magnetic field to obtain a whey hydrolysate.

[0064] (3) Isoelectric precipitation: The pH of the whey hydrolysate was adjusted to 4.8 with 1 mol / L sodium hydroxide solution, incubated in a 60°C water bath for 80 min, centrifuged at 5000 rpm for 25 min, and the supernatant was collected to obtain a whey fraction;

[0065] (4) primary ultrafiltration: the whey separator was subjected to cross-flow ultrafiltration using an ultrafiltration membrane with a molecular weight cutoff of 30 KDa, under the following conditions: a cross-flow flow rate of 7 L / min and a pressure of 0.45 MPa, during which an equal volume of pure water was added once for each filtrate of one third of the volume of the whey separator collected, and the addition was performed 15 times in total to obtain a whey ultrafiltration filtrate;

[0066] (5) Secondary ultrafiltration: The whey ultrafiltration filtrate is subjected to cross-flow ultrafiltration using an ultrafiltration membrane with a molecular weight cutoff of 1 KDa, under the following conditions: a cross-flow flow rate of 7 L / min, a pressure of 0.75 MPa, and the volume of the whey ultrafiltration filtrate is concentrated to 5.3% of the original volume to obtain a whey ultrafiltration retentate;

[0067] (6) Purification: The whey ultrafiltration retentate was pumped into a cation exchange resin column at a rate of 2 ml / min, and eluted at 40° C. using 0.05 mol / L phosphate buffer with a pH of 7.0 at a rate of 2.6 ml / min until no protein was detected to obtain an eluate, and the eluate was subjected to cross-flow ultrafiltration using an ultrafiltration membrane with a molecular weight cutoff of 1 kDa under the following conditions: a cross-flow flow rate of 7 L / min and a pressure of 0.75 MPa, and concentrated to 3% of the original volume, and the retentate was taken to obtain a whey concentrate;

[0068] (7) Sterilization and freeze-drying: The whey concentrate is placed in a high-voltage pulse electric field, treated at 10°C for 15 seconds, and vacuum freeze-dried for 20 hours to obtain colostrum alkaline protein.

[0069] Comparative Example 1:

[0070] The difference between the preparation process of colostrum alkaline protein in Comparative Example 1 and Example 2 is that step (2) is not performed, and step (3) is modified as follows: isoelectric precipitation: the pH of the whey liquid is adjusted to 4.8 with 1 mol / L sodium hydroxide solution, the whey liquid is water bathed at 60° C. for 75 min, centrifuged at 4500 rpm for 28 min, and the supernatant is taken to obtain a whey separated liquid. The remaining steps are the same as in Example 2.

[0071] Comparative Example 2:

[0072] The difference between the preparation process of colostrum alkaline protein in comparative example 1 and that in embodiment 2 is that step (3) is not performed, and step (4) is modified as follows: one ultrafiltration: the whey enzymatic solution is subjected to cross-flow ultrafiltration using an ultrafiltration membrane with a molecular weight cut-off of 30 KDa, under the conditions of a cross-flow flow rate of 6.5 L / min and a pressure of 0.5 MPa, during which an equal volume of pure water is added once for each filtrate of one third of the volume of the whey separator collected, and a total of 13 additions are made to obtain a whey ultrafiltration filtrate. The remaining steps are the same as in embodiment 2.

[0073] Comparative Example 3:

[0074] The difference between the preparation process of colostrum basic protein in Comparative Example 1 and Example 2 is that step (6) is not performed, and step (7) is modified as follows: sterilization and freeze drying: placing the whey ultrafiltration retentate in a high-voltage pulse electric field, treating it at 8° C. for 18 seconds, and vacuum freeze drying it for 18 hours to obtain colostrum basic protein. The remaining steps are the same as in Example 2.

[0075] Test Example 1:

[0076] Basic performance test: The prepared colostrum alkaline protein was tested according to the relevant standards of colostrum alkaline protein in the 2009 Ministry of Health Announcement No. 12. The test items are protein content, moisture, and ash. The standard requires that the protein content should not be less than 80%, the moisture should not be higher than 7%, and the ash should not be higher than 3%. The moisture in colostrum alkaline protein was tested with reference to GB 5009.3-2016, using the direct drying method; the total ash in colostrum alkaline protein was tested with reference to GB 5009.4-2016; the protein content in colostrum alkaline protein was tested with reference to GB 5009.5-2016, using the combustion method. Each group of samples was tested 5 times, and the average value was recorded.

[0077] The results are shown in Table 1.

[0078] Table 1

[0079] Protein Content Moisture Ash Example 1 85.43% 6.57% 2.15% Example 2 85.87% 6.52% 2.06% Example 3 84.34% 6.61% 2.18% Comparative Example 1 82.16% 6.74% 2.33% Comparative Example 2 83.45% 6.83% 2.39% Comparative Example 3 82.67% 6.81% 2.28%

[0080] From the comparison of the experimental data of Examples 1 to 3 and Comparative Examples 1 to 3 in Table 1, it can be found that the colostrum alkaline protein prepared by the present invention meets the protein content, moisture content and ash content required by the standards.

[0081] Test Example 2:

[0082] Allergenicity test: BALB / c mice were used to construct an allergenicity model to test the allergenicity of the prepared colostrum basic protein. The specific test method is as follows:

[0083] 80 SPF-grade BALB / c mice, female, 4-5 weeks old, weighing 16.0±2.0g, were selected and randomly divided into 8 groups. The mice were immunized after 7 days of adaptation. On days 0, 7, 14, and 21, each group of mice was sensitized by intraperitoneal injection, 0.2mL / mouse. Among them, 6 groups were injected with 100μg of prepared colostrum basic protein and 2mg aluminum adjuvant, 1 group was injected with only 2mg aluminum adjuvant as a blank group, and one group was injected with 100μg whey protein and 2mg aluminum adjuvant. On the 28th day, a large dose of protein was stimulated and sensitized once, and each group was gavaged with 10mg of the corresponding protein, and the blank group was not gavaged. After each sensitization, the symptoms of the mice were scored according to the allergy symptom scoring table, and the average of the sensitization scores of 5 times was recorded. The allergy symptom scoring table is as follows:

[0084] 0 points: no symptoms;

[0085] 1 point: scratching the nose and head;

[0086] 2 points: swelling around the eyes / lips / nose; hair standing on end; diarrhea or loose stools;

[0087] 3 points: Violent reaction after stimulation, such as screaming, jumping, aggressive behavior, etc.; Difficulty breathing: Strong chest rise and fall during breathing, gasping; Cyanosis (purple) appears around the nose and lips and around the tail;

[0088] 4 points: no activity after stimulation, twitching;

[0089] 5 points: Death.

[0090] The results are shown in Table 2.

[0091] Table 2

[0092] Allergy symptom score Allergy symptom score Example 1 0.24 Comparative Example 1 1.76 Example 2 0.18 Comparative Example 2 1.92 Example 3 0.2 Comparative Example 3 2.38 Blank Group 0 Control group 3.66

[0093] From the comparison of the experimental data of Examples 1 to 3 and Comparative Examples 1 to 3 in Table 2, it can be found that the colostrum basic protein prepared by the present invention has low allergenicity.

[0094] By comparing the data in the table, it is shown that the enzymatic hydrolysis, isoelectric precipitation and purification steps effectively remove α-lactalbumin and β-lactoglobulin, reduce the allergenicity of colostrum basic protein, and expand its application range.

[0095] The specific implementation methods described above further illustrate the objectives, technical solutions and beneficial effects of the present invention in detail. It should be understood that the above description is only a specific implementation method of the present invention and is not intended to limit the scope of protection of the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the scope of protection of the present invention.

Claims

1. A process for preparing colostrum basic protein, It is characterized in that The preparation process mainly includes the following steps: defatting and removing casein, enzymatic hydrolysis, isoelectric precipitation, primary ultrafiltration, secondary ultrafiltration, purification, sterilization and freeze-drying; The enzymatic hydrolysis is performed using magnetically immobilized pepsin; The primary ultrafiltration is performed using an ultrafiltration membrane cross-flow with a molecular weight cut-off of 30 KDa; The secondary ultrafiltration is carried out by cross-flow using an ultrafiltration membrane with a molecular weight cut-off of 1 KDa; The purification uses cation exchange resin for adsorption and elution; The magnetically immobilized pepsin is prepared by immobilizing pepsin on modified silica shell magnetic nanoparticles; The modified silicon shell magnetic nanoparticles are prepared by sequentially modifying magnetic ferrosoferric oxide nanoparticles with tetraethyl orthosilicate and 3-(2,3-epoxypropoxy)propyltriethoxysilane.

2. A process for preparing colostrum basic protein according to claim 1, It is characterized in that The preparation process of colostrum basic protein mainly comprises the following steps: (1) Degreasing and removing casein: fresh bovine colostrum is centrifuged at 4000-5000 rpm and 4°C for 15-20 min, the upper layer of fat is discarded, the clear liquid is adjusted to pH 4.6 with 1 mol / L hydrochloric acid aqueous solution, allowed to stand for 30-40 min, centrifuged at 4000-5000 rpm and 4°C for 15-20 min, and the whey liquid is filtered; (2) Enzymatic hydrolysis: the pH of the whey liquid was adjusted to 2.0 with a 2 mol / L hydrochloric acid aqueous solution, and the whey liquid was placed in a water bath at 37° C. for 10 to 12 min, and magnetic immobilized pepsin was added in a mass ratio of magnetic immobilized pepsin to whey liquid of 1:(20 to 25), and the whey liquid was placed in a constant temperature water bath at 37° C. at 150 to 200 r / min for 1.5 to 2 h, and the magnetic immobilized pepsin was separated by applying an external magnetic field to obtain a whey hydrolyzate; (3) Isoelectric precipitation: The whey enzymatic hydrolysate was adjusted to pH 4.8 with 1 mol / L sodium hydroxide solution, incubated in a 60°C water bath for 70-80 min, centrifuged at 4000-5000 rpm for 25-30 min, and the supernatant was collected to obtain a whey fraction; (4) primary ultrafiltration: the whey separation liquid is subjected to cross-flow ultrafiltration using an ultrafiltration membrane with a molecular weight cut-off of 30 KDa, under the following conditions: a cross-flow flow rate of 6 to 7 L / min, a pressure of 0.45 to 0.55 MPa, and water is replenished during the process to obtain a whey ultrafiltration filtrate; (5) secondary ultrafiltration: the whey ultrafiltration filtrate is subjected to cross-flow ultrafiltration using an ultrafiltration membrane with a molecular weight cut-off of 1 KDa, under the following conditions: a cross-flow flow rate of 6 to 7 L / min, a pressure of 0.75 to 0.85 MPa, and the volume of the whey ultrafiltration filtrate is concentrated to 4.4% to 5.3% of the original volume to obtain a whey ultrafiltration retentate; (6) Purification: The whey ultrafiltration retentate is pumped into a cation exchange resin column at a rate of 1.5 to 2 ml / min, and eluted at 40° C. using 0.05 mol / L phosphate buffer with a pH of 7.0 at a rate of 2.4 to 2.6 ml / min until no protein is detected to obtain an eluate, and the eluate is subjected to cross-flow ultrafiltration using an ultrafiltration membrane with a molecular weight cutoff of 1 kDa under the following conditions: a cross-flow flow rate of 6 to 7 L / min and a pressure of 0.75 to 0.85 MPa, and concentrated to 2% to 3% of the original volume, and the retentate is taken to obtain a whey concentrate; (7) Sterilization and freeze-drying: The whey concentrate is placed in a high-voltage pulse electric field, treated at 5-10°C for 15-20 seconds, and vacuum freeze-dried for 16-20 hours to obtain colostrum alkaline protein.

3. A process for preparing colostrum basic protein according to claim 2, It is characterized in that The preparation method of the magnetically immobilized pepsin in step (2) comprises the following preparation steps: (A) By weight, 0.5-0.6 parts of magnetic ferroferric oxide nanoparticles, 3-4 parts of 2.7 mol / L ammonia water, 40-60 parts of ethanol, and 10-15 parts of pure water were mixed evenly, ultrasonically dispersed for 50-60 minutes, 0.8-1.2 parts of tetraethyl orthosilicate were added dropwise at a rate of 1-2 drops per second, stirred at 200-300 r / min for 5-6 hours at room temperature, allowed to stand for 2-3 hours, separated by applying a magnetic field, washed with pure water until neutral, then washed with anhydrous ethanol and ether for 3-4 times each, and vacuum dried at 60-80° C. for 10-12 hours to obtain silicon shell magnetic nanoparticles; (B) mixing silica shell magnetic nanoparticles, 3-(2,3-epoxypropoxy)propyltriethoxysilane and ethanol in a mass ratio of 1:0.4:10, ultrasonicating at room temperature for 30 to 40 minutes, allowing to stand for 1 to 1.5 hours, separating by applying a magnetic field, vacuum drying at 30 to 40°C for 20 to 30 minutes, sealing in a 40°C water atmosphere for 30 to 40 minutes, allowing to stand in an oven at 60 to 70°C for 12 to 14 hours, washing with ethanol 3 to 4 times, and vacuum drying at 40 to 50°C for 3 to 4 hours to obtain modified silica shell magnetic nanoparticles; (C) 1 mg / ml pepsin buffer solution and modified silica shell magnetic nanoparticles were mixed uniformly in a mass ratio of 1:(0.1-0.2), and stirred at 150-200 r / min for 8-10 h in a constant temperature water bath at pH 4 at 15-25°C. The mixture was separated by an external magnetic field, washed with deionized water for 5-6 times, and vacuum dried at 15-20°C for 8-10 h to obtain magnetic immobilized pepsin.

4. A process for preparing colostrum basic protein according to claim 2, It is characterized in that The water replenishment in step (4) is to replenish an equal volume of pure water once for every filtrate of one third of the volume of the whey separator collected, and replenish 12 to 15 times in total.

5. A process for preparing colostrum basic protein according to claim 2, It is characterized in that The cation exchange resin in step (6) is one of D72, D61, D81, D113, D001, and 001×7.

6. A process for preparing colostrum basic protein according to claim 2, It is characterized in that The field intensity of the high-voltage pulse electric field in step (7) is 30 to 50 kV / cm, and the pulse frequency is 200 to 400 Hz.

7. A process for preparing colostrum basic protein according to claim 3, It is characterized in that The particle size of the magnetic ferroferric oxide nanoparticles in step (A) is 15 to 20 nm.